7 research outputs found
Efavirenz plasma concentrations at sampling time.
<p>Efavirenz plasma concentrations at sampling time.</p
Efavirenz concentrations at week 22 and week 50 in patients whose efavirenz concentrations >4,000 ng/mL.
<p>Efavirenz concentrations at week 22 and week 50 in patients whose efavirenz concentrations >4,000 ng/mL.</p
Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampling time.
<p>Distribution of efavirenz plasma concentrations according to the therapeutic range at each sampling time.</p
Characteristics of the 540 patients at ART initiation.
<p>ART: Antiretroviral Treatment; IQR: interquartile range; AST: aspartate aminotransferase; ALT: alanine aminotransferase.</p
Univariate and multivariate analysis of risk factors associated with efavirenz plasma concentration below 1,000/mL.
<p>Percentiles are gender-specific. IRIS: paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome.</p><p>Sampling times were: 2 weeks after ART initiation, 6 weeks after ART initiation, at 22 weeks of follow-up, and at 50 weeks of follow-up. See text for details.</p